Literature DB >> 18635734

Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population.

Lena Strand Bergström1, Niels Lynöe.   

Abstract

AIM: To study attitudes towards enhancing concentration, mood and memory in healthy individuals among the general public and general practitioners (GPs).
METHODS: A questionnaire consisting of vignettes including three cases dealing with enhancement of concentration, mood and memory was sent during 2006 to 1000 randomly selected people from Stockholm and 300 GPs. We asked about the use of pharmaceuticals for healthy individuals for the benefit of others and the benefit to oneself; we also asked whether or not society should pay the cost. Finally, we asked about enhancement of healthy people's concentration, mood and memory through the use of natural remedies.
RESULTS: Fifty-two per cent of the general public and 39% of the GPs responded. While the use of natural remedies was perceived as fairly acceptable, majorities in both groups were negative with regard to the use of pharmaceuticals to enhance concentration, mood and memory in a healthy individual. The general public tended to be less negative than the GPs. There was a significant difference between the reasons for providing enhancement; altruistic reasons seem to be more acceptable than egoistic ones. For both groups, enhancing mood was more controversial than enhancing memory.
CONCLUSIONS: Despite the large dropout rate, the study indicates that enhancement by means of natural remedies of different human capacities is acceptable to the general public, while only small minorities of both groups are inclined to allow the use of pharmaceuticals. When compared to the egoistic reason, the altruistic one for enhancing concentration, mood and memory with pharmaceuticals seems to influence the general public's inclination to support prescriptions; this was also the case among the GPs, but only as regards mood enhancement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635734     DOI: 10.1177/1403494807087558

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  14 in total

1.  Should physicians prescribe cognitive enhancers to healthy individuals?

Authors:  Cynthia Forlini; Serge Gauthier; Eric Racine
Journal:  CMAJ       Date:  2012-12-17       Impact factor: 8.262

2.  Navigating the enhancement landscape. Ethical issues in research on cognitive enhancers for healthy individuals.

Authors:  Cynthia Forlini; Wayne Hall; Bruce Maxwell; Simon M Outram; Peter B Reiner; Dimitris Repantis; Maartje Schermer; Eric Racine
Journal:  EMBO Rep       Date:  2013-01-15       Impact factor: 8.807

Review 3.  Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement.

Authors:  Cynthia Forlini; Eric Racine
Journal:  BMC Med Ethics       Date:  2009-07-06       Impact factor: 2.652

4.  Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.

Authors:  Opeyemi C Banjo; Roland Nadler; Peter B Reiner
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

5.  Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany.

Authors:  Andreas G Franke; Carolin Papenburg; Elena Schotten; Peter B Reiner; Klaus Lieb
Journal:  BMC Fam Pract       Date:  2014-01-08       Impact factor: 2.497

Review 6.  Attitudes toward pharmacological cognitive enhancement-a review.

Authors:  Kimberly J Schelle; Nadira Faulmüller; Lucius Caviola; Miles Hewstone
Journal:  Front Syst Neurosci       Date:  2014-04-17

7.  Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland.

Authors:  Ilina Singh; Imre Bard; Jonathan Jackson
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

8.  Cognitive biases can affect moral intuitions about cognitive enhancement.

Authors:  Lucius Caviola; Adriano Mannino; Julian Savulescu; Nadira Faulmüller
Journal:  Front Syst Neurosci       Date:  2014-10-15

9.  Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement.

Authors:  Sebastian Sattler; Cynthia Forlini; Eric Racine; Carsten Sauer
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  The rationale for consuming cognitive enhancement drugs in university students and teachers.

Authors:  Sebastian Sattler; Carsten Sauer; Guido Mehlkop; Peter Graeff
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.